Accessibility Menu
 
Nkarta logo

Nkarta

(NASDAQ) NKTX

Current Price$2.31
Market Cap$165.39M
Since IPO (2020)-95%
5 Year-93%
1 Year+21%
1 Month-10%

Nkarta Financials at a Glance

Market Cap

$165.39M

Revenue (TTM)

$0.00

Net Income (TTM)

$104.08M

EPS (TTM)

$-1.41

P/E Ratio

-1.65

Dividend

$0.00

Beta (Volatility)

1.53 (High)

Price

$2.31

Volume

21,812

Open

$2.15

Previous Close

$2.31

Daily Range

$2.15 - $2.32

52-Week Range

$1.42 - $2.81

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nkarta

Industry

Biotechnology

Employees

108

CEO

Paul J. Hastings

Headquarters

South San Francisco, CA 94080, US

NKTX Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-29%

Return on Capital

-32%

Return on Assets

-26%

Earnings Yield

-60.61%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$165.39M

Shares Outstanding

71.29M

Volume

21.81K

Short Interest

0.00%

Avg. Volume

756.98K

Financials (TTM)

Gross Profit

$9.19M

Operating Income

$121.21M

EBITDA

$112.01M

Operating Cash Flow

$88.70M

Capital Expenditure

$1.21M

Free Cash Flow

$89.91M

Cash & ST Invst.

$276.28M

Total Debt

$76.42M

Nkarta Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$2.26M

N/A

Gross Margin

0.00%

N/A

Market Cap

$165.39M

N/A

Market Cap/Employee

$1.05M

N/A

Employees

157

N/A

Net Income

$27.41M

-5.7%

EBITDA

$28.70M

-0.2%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$199.86M

+6.8%

Accounts Receivable

$2.00M

+900.0%

Inventory

$0.00

N/A

Long Term Debt

$69.53M

-6.3%

Short Term Debt

$6.89M

+13.9%

Return on Assets

-25.75%

N/A

Return on Invested Capital

-31.94%

N/A

Free Cash Flow

$22.21M

+14.1%

Operating Cash Flow

$21.65M

+12.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MOLNMolecular Partners AG
$3.85-3.87%
FATEFate Therapeutics, Inc.
$1.22-1.61%
ELTXElicio Therapeutics, Inc.
$10.65-0.09%
VORVor Biopharma Inc.
$18.05+3.80%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
INTCIntel
$50.38+0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%

Questions About NKTX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.